Oncology
Microvessel counts predict melanoma recurrence after cancer therapy
Published in Cancer Weekly, September 20th, 2005
According to recent research published in the journal Histopathology, "two-hundred and four accessible cases of malignant melanoma from the Grampian region of Scotland, collected over a period of 4 years, were studied for standard prognostic indicators for comparison with microvessel density."
"The range of tumor thickness varied from in-situ melanoma to 14.8 mm. Microvessel density was assessed using the Chalkley technique on sections immunostained with CD31 antibody to identify endothelium," wrote I. Depasquale and colleagues, Aberdeen Royal Infirmary.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2005-09-20)
More Articles from Cancer Weekly
- Acute Lymphoblastic Leukemia
ALL subtypes originate, transform at distinct hematopoietic development stages - Drug Delivery
Intratumoral injection of BCNU in ethanol resulted in enhanced delivery to tumor - Imaging Modality
Pitfalls of interpreting whole-body PET/CT images highlighted - Lung Cancer
Fluorescence in situ hybridization compared with conventional cytology - Prognostics
Reclassification of renal cell carcinoma patients improved prognostic accuracy - Adjuvant Cancer Therapy
Guided imagery as adjuvant cancer therapy reviewed - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
